PharmiWeb
Biotest increases sales in the first half of 2024 by 35% to Euro 372 million
In the first half of the 2024 financial year, the Biotest Group generated revenue of € 372.0 million. This corresponds to growth of 35.1% compared to the revenue of € 275.3 million generated in the same period of the previous year.
3 days ago